Fluticasone: profile and news

Tercica to Present at Ninth Annual Lehman Brothers' Global Health ... 07 Mar 2006
The company's first product, Increlex(TM) (mecasermin (rDNA origin) injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the ... - Genetic Engineering News,

Insmed Incorporated Announces Proposed Public Offering of Common ... 07 Mar 2006
For further information about Insmed and IPLEX(TM)(mecasermin rinfabate, rDNA origin, injection), our FDA-approved drugfor the treatment of growth failure in ... - Finanzen.net,

Apidra (insulin glulisine [rDNA origin] injection) Now Available ... Feb 28, 2006
BRIDGEWATER, NJ -- February 28, 2006 -- Sanofi-aventis US announced today that Apidra® (insulin glulisine [rDNA origin] injection), a new prandial or mealtime ... - DG News

Apidra(R) - a New Rapid-Acting Insulin Analog - Is Now Available ... Feb 28, 2006
28 /PRNewswire-FirstCall/ -- Sanofi-aventis US announced today that Apidra(R) (insulin glulisine [rDNA origin] injection), a new prandial or mealtime insulin ... - PR Newswire (press release),

Apidra - a New Rapid-Acting Insulin Analog - Is Now Available in ... Feb 28, 2006
BRIDGEWATER, NJ, February 28, 2006 /PRNewswire-FirstCall/ -- Sanofi-aventis US announced today that Apidra(R) (insulin glulisine [rDNA origin] injection), a ... - PharmaLive.com (press release),

Apidra(R) - a New Rapid-Acting Insulin Analog - Is Now Available ... Feb 28, 2006
28 /PRNewswire-FirstCall/ -- Sanofi-aventis US announced today that Apidra® (insulin glulisine [rDNA origin] injection), a new prandial or mealtime insulin ... - Yahoo! News (press release)

Sanofi's Apidra hits the US market Mar 2, 2006
Sanofi says Apidra (insulin glulisine rDNA origin injection) is to be used in regimens that include a longer-acting insulin or basal insulin analog such as ... - Pharmaceutical Business Review

NPS Pharmaceuticals Reports Fourth Quarter and Year-End Operating ... Feb 16, 2006
...* Filing the PREOS(R) (parathyroid hormone [rDNA origin] for injection) new drug application (NDA) in the United States and the Preotact(TM) marketing ... - MSN Money

CHMP Recommends Authorization to Market Preotact (PREOS) in Europe Feb 23, 2006
Medicines Agency has adopted a positive opinion recommending authorization for Nycomed to market Preotact® (parathyroid hormone [rDNA origin] for injection ... - DG News

Tercica Reports Fourth Quarter Financial Results; Conference Call ... Feb 15, 2006
Completion of the manufacturing, distribution and commercial operations requirements necessary to launch Increlex (mecasermin (rDNA origin) injection) in ... - Genetic Engineering News,

CHMP Recommends Authorization to Market Preotact(R) (PREOS(R)) in ... Feb 23, 2006
...www.emea.eu.int) has adopted a positive opinion recommending authorization for Nycomed to market Preotact® (parathyroid hormone [rDNA origin] for injection ... - Yahoo! News (press release)

NPS Pharmaceuticals Reports Fourth Quarter and Year-End Operating ... Feb 16, 2006
The company's accomplishments in 2005 included: * Filing the PREOS(R) (parathyroid hormone [rDNA origin] for injection) new drug application (NDA) in the ... - CNW Telbec (Communiqués de presse),

Lilly launches new diabetes product Feb 8, 2006
The new formula, which comprises 50% insulin lispro protamine suspension and 50% insulin lispro injection (rDNA origin), is now available in an easy-to-use pen ... - Pharmaceutical Business Review

Lilly Launches Humalog® Mix50/50™ Insulin In United States Feb 12, 2006
LLY) announces the launch of a new pre-mixed insulin, Humalog® Mix50/50™ (50% insulin lispro protamine suspension, 50% insulin lispro injection (rDNA origin ... - Medical News Today (press release),

Lilly Launches Humalog Mix50/50 Insulin in United States Feb 7, 2006
...announces the launch of a new pre-mixed insulin, Humalog(R) Mix50/50(TM) (50% insulin lispro protamine suspension, 50% insulin lispro injection (rDNA origin)). ... - PharmaLive.com (press release),

Former Professor Sued For Patent Infringement Feb 9, 2006
The US Food and Drug Administration (FDA) has approved the inhalable formulation of recombinant human insulin [rDNA origin] powder for the treatment of adult ... - Patent Baristas,

NPS Pharmaceuticals Reports Fourth Quarter and Year-End Operating ... Feb 16, 2006
...with the same periods in the prior year are primarily due to decreases in the development costs of the PREOS(R) (parathyroid hormone [rDNA origin] for injection ... - PharmaLive.com (press release),

Former Professor Sued For Patent Infringement 09 Feb 2006
The US Food and Drug Administration (FDA) has approved the inhalable formulation of recombinant human insulin [rDNA origin] powder for the treatment of adult ... - Patent Baristas,

Pfizer Receives FDA Approval for Exubera, the First Inhalable Form ... Jan 27, 2006
27 /PRNewswire-FirstCall/ -- Pfizer Inc said today that Exubera(R) (insulin human [rDNA origin]) Inhalation Powder has been approved by the US Food and Drug ... - PR Newswire (press release),

FDA Approves Exubera, First Inhalable Form Of Insulin For ... Jan 29, 2006
Pfizer Inc said that Exubera® (insulin human [rDNA origin]) Inhalation Powder has been approved by the US Food and Drug Administration for the treatment of ... - Medical News Today (press release),

Pfizer Receives FDA Approval for Exubera, the First Inhaleable ... Jan 27, 2006
Nektar Therapeutics (Nasdaq:NKTR) today reported that Pfizer Incsaid that Exubera(R) (insulin human (rDNA origin)) Inhalation Powderhas been approved by the US ... - Finanzen.net,

Innovative Hand-Held Insulin Device Effectively Controls Diabetes ... Jan 27, 2006
January 28, 2006 Pfizer’s Exubera (insulin human [rDNA origin]) Inhalation Powder has been approved by the US Food and Drug Administration for the treatment ... - Gizmag,

Inhaled Human Insulin Approved for Diabetes Treatment Jan 27, 2006
By Pfizer, Pfizer Inc said today that Exubera® (insulin human [rDNA origin]) Inhalation Powder has been approved by the US Food and Drug Administration for ... - RxPG NEWS,

Senior Diabetics Say Goodbye to Injections as FDA Welcomes Exubera Jan 28, 2006
Pfizer also said Exubera (insulin human [rDNA origin]) Inhalation Powder has been approved for the treatment of adults with type 1 and type 2 diabetes. ... - SeniorJournal.com,

Pfizer Receives FDA Approval for Exubera, the First Inhaleable ... Jan 28, 2006
Nektar Therapeutics (Nasdaq:NKTR) today reported that Pfizer Inc (Nachrichten/Aktienkurs) said that Exubera(R) (insulin human (rDNA origin)) Inhalation Powder ... - FinanzNachrichten.de,

Pfizer Receives FDA Approval for Exubera, The First Inhalable Form Jan 31, 2006
New York, NY--(HISPANIC PR WIRE)--January 31, 2005--Pfizer Inc said today that Exubera(R) (insulin human [rDNA origin]) Inhalation Powder has been approved by ... - HispanicBusiness.com,

Tercica to Hold 2005 Fourth Quarter and Year End Financial Results ... Feb 1, 2006
The company's first product, Increlex(TM) (mecasermin (rDNA origin) injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the ... - Genetic Engineering News,

Pfizer Receives FDA Approval for Exubera, the First Inhalable Form ... Jan 27, 2006
NEW YORK, January 27, 2006 /PRNewswire-FirstCall/ -- Pfizer Inc said today that Exubera(R) (insulin human [rDNA origin]) Inhalation Powder has been approved by ... - PharmaLive.com (press release),

Pfizer Receives FDA Approval for Exubera, the First Inhaleable ... Jan 27, 2006
Nektar Therapeutics (Nasdaq:NKTR) today reported that Pfizer Inc said that Exubera(R) (insulin human (rDNA origin)) Inhalation Powder has been approved by the ... - Business Wire (press release),

Pfizer Receives FDA Approval for Exubera and CytoDyn Annual ... Jan 30, 2006
...industry news provided by Financial News USA (OTC: FNWU) Pfizer Inc (NYSE:PFE) said recently that Exubera® (insulin human [rDNA origin]) Inhalation Powder has ... - Financial News USA (press release),

Novo Nordisk Introduces New Storage Flexibility For Norditropin® ... Jan 29, 2006
Novo Nordisk today announced that Norditropin NordiFlex® (somatropin [rDNA origin] injection) 5 mg and 10 mg, the only prefilled, multi-dose, disposable ... - Medical News Today (press release),

FDA APPROVES Exubera(R) Jan 31, 2006
...(insulin human [rDNA origin]) Inhalation Powder THE FIRST INHALED INSULIN FOR THE TREATMENT OF ADULTS WITH TYPE 1 AND TYPE 2 DIABETES ADDITIONAL RESOURCES ... - PR Newswire (press release),

MultiVu Video Feed: FDA Approves Exubera(R) (insulin human [rDNA ... Jan 27, 2006
NEW YORK, Jan. 27 /PRNewswire/ -- Nearly 21 million Americans suffer from diabetes and the majority of those with type 2 diabetes ... - Yahoo! News (press release)

Alkermes and Lilly Announce Agreement for the Development and ... Jan 10, 2006
Lilly's recombinant PTH, Forteo® (teriparatide (rDNA origin) injection), was approved in 2002 by the Food and Drug Administration (FDA) for the treatment of ... - Chemie.de (press release),

Alkermes and Lilly Announce Agreement for the Development and ... Jan 9, 2006
Lilly's recombinant PTH, Forteo(R) (teriparatide (rDNA origin) injection), was approved in 2002 by the Food and Drug Administration (FDA) for the treatment of ... - Genetic Engineering News,

Novo Nordisk Introduces New Storage Flexibility for Norditropin(R) Jan 11, 2006
11 /PRNewswire-FirstCall/ -- Novo Nordisk today announced that Norditropin NordiFlex® (somatropin [rDNA origin] injection) 5 mg and 10 mg, the only prefilled ... - Yahoo! News (press release)

Novo Nordisk Introduces New Storage Flexibility for Norditropin Jan 11, 2006
PRINCETON, NJ, January 11, 2006 /PRNewswire-FirstCall/ -- Novo Nordisk today announced that Norditropin NordiFlex(R) (somatropin [rDNA origin] injection) 5 mg ... - PharmaLive.com (press release),

Novo Nordisk Introduces New Storage Flexibility for Norditropin Jan 11, 2006
PRINCETON, NJ -- January 11, 2006 -- Novo Nordisk today announced that Norditropin NordiFlex(R) (somatropin [rDNA origin] injection) 5 mg and 10 mg, the only ... - DG News